Proven results

Normal to Oily
Clinical studies show that the CLENZIderm M.D. Normal to Oily System significantly reduces follicular P. acnes bacteria compared to a leading BPO/clindamycin combination. Reduction in follicular P. acnes was apparent immediately after a single application and sustained improvement through eight hours. The Normal to Oily System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions for results your patients can see and feel.

Before

After 4 Weeks

Effectively Used Once Daily

The CLENZIderm M.D. Normal to Oily System can also be used effectively once daily.*

*Postered at the 2007 Annual American Academy of Dermatology Meeting. 

Normal to Dry
The CLENZIderm M.D. Normal to Dry System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions while minimizing dryness and maximizing patient comfort.

In a recent clinical study, the following results were reported after 2 weeks of once-daily application:

• 49% reduction in inflammatory lesions
• 35% reduction in non-inflammatory lesions

Before

After 4 Weeks

Easy-to-Use, Well-Tolerated System

As a lotion-based system containing 20% glycerin and 1% dimethicone, the CLENZIderm M.D. Normal to Dry System is clinically proven to provide less drying and better overall comfort than the leading topical prescription BPO/clindamycin combination in an optimized emollient vehicle, according to a recent clinical study†:

• No patients reported dryness at Week 3 with CLENZIderm M.D.
• 91% of patients rated CLENZIderm M.D. as “Very Comfortable” at Week 3

†Postered at Winter AAD, 2008.

How it works

How are CLENZIderm M.D. Systems different than other BPO treatments?

Other BPO-based treatments are formulated with insoluble micro or macro-crystals which can remain on the surface of the skin. CLENZIderm M.D. Systems are the only prescription-strength acne therapies that contain a solubilized form of 5% BPO designed to penetrate deep into the follicle and clear acne fast.

CLENZIderm M.D. Systems demonstrate greater penetration post application

The solubilized form of 5% BPO in CLENZIderm M.D. Systems is 1/10,000 the size of any other BPO product available, so it can treat acne where it starts, at the root.

Before & After

CLENZIderm M.D. Systems are clinically proven to penetrate more effectively than leading prescription benzoyl peroxide products because of their solubilized BPO formulation. This powerful medication penetrates deep into the follicles to reduce acne where it starts—providing a visibly clearer complexion in as little as 2 weeks.

Normal to Oily System

Before

After 2 weeks

Before

After 4 weeks

Before

After 4 weeks

Normal to Dry System

Before

After 2 weeks

Before

After 2 weeks

Proven results

Normal to Oily
Clinical studies show that the CLENZIderm M.D. Normal to Oily System significantly reduces follicular P. acnes bacteria compared to a leading BPO/clindamycin combination. Reduction in follicular P. acnes was apparent immediately after a single application and sustained improvement through eight hours. The Normal to Oily System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions for results your patients can see and feel.

 

Before

After 4 Weeks

Effectively Used Once Daily

The CLENZIderm M.D. Normal to Oily System can also be used effectively once daily.*

*Postered at the 2007 Annual American Academy of Dermatology Meeting. Click here to view full study.

 

Normal to Dry
The CLENZIderm M.D. Normal to Dry System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions while minimizing dryness and maximizing patient comfort.

In a recent clinical study, the following results were reported after 2 weeks of once-daily application:

• 49% reduction in inflammatory lesions
• 35% reduction in non-inflammatory lesions

Before

After 4 Weeks

Easy-to-Use, Well-Tolerated System

As a lotion-based system containing 20% glycerin and 1% dimethicone, the CLENZIderm M.D. Normal to Dry System is clinically proven to provide less drying and better overall comfort than the leading topical prescription BPO/clindamycin combination in an optimized emollient vehicle, according to a recent clinical study†:

• No patients reported dryness at Week 3 with CLENZIderm M.D.
• 91% of patients rated CLENZIderm M.D. as “Very Comfortable” at Week 3

†Postered at Winter AAD, 2008. Click here to view full study.

How it works

How are CLENZIderm M.D. Systems different than other BPO treatments?

Other BPO-based treatments are formulated with insoluble micro or macro-crystals which can remain on the surface of the skin. CLENZIderm M.D. Systems are the only prescription-strength acne therapies that contain a solubilized form of 5% BPO designed to penetrate deep into the follicle and clear acne fast.

CLENZIderm M.D. Systems demonstrate greater penetration post application

The solubilized form of 5% BPO in CLENZIderm M.D. Systems is 1/10,000 the size of any other BPO product available, so it can treat acne where it starts, at the root.

Before & After

CLENZIderm M.D. Systems are clinically proven to penetrate more effectively than leading prescription benzoyl peroxide products because of their solubilized BPO formulation. This powerful medication penetrates deep into the follicles to reduce acne where it starts—providing a visibly clearer complexion in as little as 2 weeks.

Normal to Oily System

Before

After 2 weeks

Before

After 4 weeks

Before

After 4 weeks

Normal to Dry System

Before

After 2 weeks

Before

After 2 weeks

Proven results

Normal to Oily
Clinical studies show that the CLENZIderm M.D. Normal to Oily System significantly reduces follicular P. acnes bacteria compared to a leading BPO/clindamycin combination. Reduction in follicular P. acnes was apparent immediately after a single application and sustained improvement through eight hours. The Normal to Oily System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions for results your patients can see and feel.

 

Before

After 4 Weeks

Effectively Used Once Daily

The CLENZIderm M.D. Normal to Oily System can also be used effectively once daily.*

*Postered at the 2007 Annual American Academy of Dermatology Meeting. Click here to view full study.

 

Normal to Dry
The CLENZIderm M.D. Normal to Dry System is clinically proven to provide fast clearance of inflammatory and non-inflammatory acne lesions while minimizing dryness and maximizing patient comfort.

In a recent clinical study, the following results were reported after 2 weeks of once-daily application:

• 49% reduction in inflammatory lesions
• 35% reduction in non-inflammatory lesions

Before

After 4 Weeks

Easy-to-Use, Well-Tolerated System

As a lotion-based system containing 20% glycerin and 1% dimethicone, the CLENZIderm M.D. Normal to Dry System is clinically proven to provide less drying and better overall comfort than the leading topical prescription BPO/clindamycin combination in an optimized emollient vehicle, according to a recent clinical study†:

• No patients reported dryness at Week 3 with CLENZIderm M.D.
• 91% of patients rated CLENZIderm M.D. as “Very Comfortable” at Week 3

†Postered at Winter AAD, 2008. Click here to view full study.